Skip to content

Efficacy and safety of intermittent bolus comparing with traditional continuous drip of 3% NaCl in patients with severe symptomatic hyponatremia at Kranuan Crown Prince Hospital.

Efficacy and safety of intermittent bolus comparing with traditional continuous drip of 3% NaCl in patients with severe symptomatic hyponatremia at Kranuan Crown Prince Hospital.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240716002
Enrollment
42
Registered
2024-07-16
Start date
2024-01-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pateints with Severe symptomatic hyponatremia. Severe symptomatic hyponatremia

Interventions

We use 3 % NaCl iv bolus in 30 min until achieve target pNa more than 5 mEq/L and improve Glasglow Coma Scale.,We use 3 % NaCl iv drip start 1 ml/Kg/hr and adjust according to protocol to achieve targ
Experimental Drug,Active Comparator Drug
3 % NaCl bolus ,3 % NaCl drip

Sponsors

Orakan Lanwong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Patients who are visitting at Emergency room or admitted in Kranuan Crown Prince hospital. 2.Age older than 18 years old. 3.Glucose-corrected plasma sodium less than 125 mmol per L. 4.Severe symptoms (vomiting, drowsy, seizure and coma). 5.Body weight more than or equal 45 kg.

Exclusion criteria

Exclusion criteria: 1.Hypotension (systolic blood pressure less than 90 mmol per L) or mean arterial pressure less than 70 mmol per L. 2.Pregnancy or breast feeding. 3.Previous history of volume overload or congestive heart failure (CHF). 4.Patients with lung congestion from chest X-ray. 5.Chronic kidney disease with edema. 6.Cirrhosis with edema. 7.Patients with symptoms of CAD, VHD and arrythmia. 8.Patients with brain injuries or increased intracranial pressure that is not from hyponatremia. 9.Patients who have critical illness suc as respiratory failure,sepsis or multiorgan failure 10.Deny consent form.

Design outcomes

Primary

MeasureTime frame
Time to achieve target in pNa and improvement of Glasglow Coma Scale (GCS). at 6 hours after treatment minutes

Secondary

MeasureTime frame
Changes in pNa 6 hr after treatment mEq/L ,overcorrection rate in 24th and 48 th hr percent,Osmotic demyelination rate 48 hr percent ,mortality rate 30 days percent

Countries

Thailand

Contacts

Public ContactOrakan Lanwong

Kranuan Crown Prince Hospital

Orakanpor@gmail.com0803625252

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026